The synthesis of bicyclic lactam based His-Pro building blocks: The effect of substituent polarity on an intramolecular bond migration

Tetrahedron Letters

Volumn 40, Issue 45, 1999, Pages 7939-7943

  Chu, Wenhua ^a   Moeller, Kevin D ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; AMIDE; IMIDAZOLE; LACTAM DERIVATIVE; PROLINE DERIVATIVE;

ARTICLE; CYCLIZATION; ELECTRON; OXIDATION; PARTIAL DRUG SYNTHESIS;

EID: 0033527781     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)01652-4     Document Type: Article

References (23)

1. For selected examples, see: (a) Li, W.; Hanau, C. E.; d'Avignon, A.; Moeller, K. D. J. Org. Chem. 1995, 60, 8155.
2. (b) Fobian, Y. M.; d'Avignon, D. A.; Moeller, K. D. Bioorg. Med. Chem. Lett. 1996, 6, 315.
3. (c) Rutledge, L. D.; Perlman, J. H.; Gershengorn, M. C.; Marshall, G. R.; Moeller, K. D. J. Med Chem. 1996, 39, 1571.
4. (e) Fobian, Y. M.; Moeller, K. D. Methods in molecular medicine; Kazmierski, W. M., Ed. Peptidomimetics Protocols. Humana Press Inc.: Totowa, NJ, 1998; Vol. 23, p. 259.
5. (f) Beal, L. M.; Moeller, K. D. Tetrahedron Lett. 1998, 39 4639.
6. (g) Tong, Y.; Fobian, Y. M.; Wu, M.; Boyd, N. D.; Moeller, K. D. Bioorg. Med. Chem. Lett. 1998, 8, 1679.
7. For reviews on the biology of TRH, see: Thyrotropin-releasing hormone: Biomedical significance; Metcalf Olson, G. L.; Cheung, H. C.; Voss, M. E.; Hill, D. E.; Kahn, M.; Madison, V. S.; Cook, C. M.; Sepinwall, J., Eds.; Proceedings of the Biotech USA 89 Meeting 1989; San Francisco, October 1989.
8. For alternative approaches to understanding TRH/TRH-R binding, see: (a) Hinkle, P. M.; Woroch, E. L.; Tashjian, G. H. J. Biol. Chem. 1974, 249, 3085.
9. (b) Goren, H. J.; Bauce, L. G.; Vale, W. Mol. Pharmacol. 1977, 13, 606.
10. (c) Kamiya, K.; Takamoto, M.; Wada, Y.; Fujino, M.; Nishikawa, M. J. Chem. Soc., Chem. Commun. 1980, 438.
11. (d) Sharif, N. A.; To, Z.; Whiting, R. L. Biochem. Biophys. Res. Commun. 1989, 161, 1306.
12. (e) Vonhof, S.; Feuerstein, G. Z.; Cohen, L. A.; Labroo, V. M. Eur. J. Pharmacol. 1990, 180, 1.
13. For a description of the active analog approach used to design the analogs 1a and 1b, see: (a) Marshall, G. R.; Gorin, F. A.; Moore, M. L. In Annual Reports in Medicinal Chemistry; Clarke, F. H., Ed.; Academic: New York, 1978; Vol. 13, p. 227.
14. (b) Font, J. Ph.D. Thesis, Washington University, St. Louis, MO, 1986.
15. (c) For an alternative application of these models to the construction of TRH mimetics, see: Olson, G. L.; Cheung, H. C.; Chiang, E.; Madison, V. S.; Sepinwall, J.; Vincent, G. P.; Winokur, A.; Gary, K. A. J. Med. Chem. 1995, 38, 2866.
16. For partially constrained analogs, see: (a) Li, W.; Moeller, K. D. J. Am. Chem. Soc. 1996, 118, 10106.
17. (b) Laakkonen, L.; Li, W.; Perlman, J. H.; Guarnieri, F.; Osman, R.; Moeller, K. D.; Gershengorn, M. C. Mol. Pharmacol. 1996, 49, 1092. For fully constrained analogs, see: Chu, W.; Perlman, J. H.; Gershengorn, M. C.; Moeller, K. D. Bioorg. Med. Chem. Lett. 1998, 8, 3093.
18. (b) Laakkonen, L.; Li, W.; Perlman, J. H.; Guarnieri, F.; Osman, R.; Moeller, K. D.; Gershengorn, M. C. Mol. Pharmacol. 1996, 49, 1092. For fully constrained analogs, see: Chu, W.; Perlman, J. H.; Gershengorn, M. C.; Moeller, K. D. Bioorg. Med. Chem. Lett. 1998, 8, 3093.
19. Moeller, K. D.; Hanau, C. E.; d'Avignon, A. Tetrahedron Lett. 1994, 35, 835.
20. Horne, D. A.; Yakushijin, K.; Büchi, G. Heterocycles 1994, 39, 139.
21. (a) d'Avignon, D. A.; Hanau, C. E.; Fobian, Y. M.; Moeller, K. D. Coordination Chem. 1994, 32, 135.
22. (b) Kao, J.; Li, W.; Moeller, K. D. Magn. Reson. Chem. 1997, 35, 267.
23. Wong, P. L.; Moeller, K. D. J. Am. Chem. Soc. 1993, 115, 11434.